BERLIN — An investigational nasal glucagon offers the potential for an easier-to-use alternative to the injected version of the hypoglycemia rescue medication, new data suggest. Findings from a ...
HealthDay News — For patients with type 1 diabetes, intranasal glucagon is effective for treating insulin-induced hypoglycemia, according to a study published online December 17 in Diabetes Care.
Please provide your email address to receive an email when new articles are posted on . Nasal glucagon was noninferior to intramuscular glucagon for treating hypoglycemia in Japanese adults with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results